Fundraising Fox
Arkstone
Founded 2018 · 43 employees on LinkedIn · 1 known investors
Find your way into Arkstone
Sign up to see every warm intro you have to Arkstone
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arkstone team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.
Founders & leadership
Arkstone was founded in 2018 by Dave Gross, Dr. Ari Frenkel, and Sol Levi.
DG
Dave GrossCo-Founder, Chief Technology OfficerDave Gross is an attorney and software executive who previously founded Empower NY, a property management compliance platform acquired by DMGT in 2015, and has held senior technology and operations roles at Fortune 1000 and startup companies. He holds a JD from Cardozo School of Law and a BA from Queens College.
DA
Dr. Ari FrenkelCo-Founder, Chief Science Officer
SL
Sol LeviCo-Founder, Chief Customer OfficerCo-founder and Chief Customer Officer of Arkstone, which develops AI-powered clinical decision support tools for appropriate antibiotic prescribing and antimicrobial stewardship.
IC
Ian CampbellCEO and Executive ChairmanIan Campbell holds a master's degree in aerospace engineering from Georgia Tech and has previously founded two venture-backed technology companies—NextInput (acquired by Qorvo) and OnScale (acquired by Ansys)—focused on advanced hardware and simulation platforms. He is currently CEO and Executive Chairman of Arkstone, which develops AI-powered clinical decision support tools for antimicrobial stewardship.
Investors · 1
Frequently asked questions
- What does Arkstone do?
- Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.
- Who founded Arkstone?
- Arkstone was founded by Dave Gross, Dr. Ari Frenkel, Sol Levi in 2018.
- Who are Arkstone's investors?
- Arkstone's investors include ARCHIMED Japan.